Anti-CrkL (phospho Y207) antibody [CrkLY207-G4] (ab278698)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- Rabbit monoclonal [CrkLY207-G4] to CrkL (phospho Y207)
- Suitable for: WB, Flow Cyt
- Reacts with: Mouse, Human
Overview
-
Product name
Anti-CrkL (phospho Y207) antibody [CrkLY207-G4]
See all CrkL primary antibodies -
Description
Rabbit monoclonal [CrkLY207-G4] to CrkL (phospho Y207) -
Host species
Rabbit -
Tested Applications & Species
See all applications and species dataApplication Species Flow Cyt MouseHumanWB MouseHuman -
Immunogen
Synthetic peptide within Human CrkL (phospho Y207). The exact immunogen sequence used to generate this antibody is proprietary information. If additional detail on the immunogen is needed to determine the suitability of the antibody for your needs, please contact our Scientific Support team to discuss your requirements.
Database link: P46109 -
Positive control
- WB: K562 and NIH/3T3 cell extracts; Mouse E10.5 whole embryo extract. Flow cyt: K562 cells (treated with pervanadate).
-
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. -
Storage buffer
Preservative: 0.02% Sodium azide
Constituents: 49.88% PBS, 50% Glycerol (glycerin, glycerine), 0.1% BSA -
Concentration information loading...
-
Purity
Protein A/G purified -
Clonality
Monoclonal -
Clone number
CrkLY207-G4 -
Isotype
IgG -
Light chain type
kappa -
Research areas
Images
-
Flow cytometric analysis of K562 cells secondary antibody only negative control (blue) or treated with imatinib (red) or with pervanadate (green) using 0.05 µg/mL of ab278698 at 0.1ug/mL.
-
All lanes : Anti-CrkL (phospho Y207) antibody [CrkLY207-G4] (ab278698) at 1/500 dilution (Green)
Lane 1 : E10.5 mouse Crkl knock out (-/-) whole embryos.
Lane 2 : E10.5 mouse wild-type (+/+) whole embryos.
Predicted band size: 34 kDaThe red channel was stained using a B-actin loading control.
-
Anti-CrkL (phospho Y207) antibody [CrkLY207-G4] (ab278698) at 1 µg/ml + NIH3T3 cell extract
Predicted band size: 34 kDa
-
Peptide blocking flow cytometric analysis of K562 cells secondary antibody only negative control (light blue) or treated with imatinib (red) or treated with pervanadate (green) or imatinib and blocked with phospho-peptide (black) or pervanadate and blocked with phospho peptide (gold) or imatinib and blocked with non-phospho peptide (dark blue) or pervanadate and blocked with non-phospho peptide (purple) using ab278698 at 0.01µg/mL.
-
All lanes : Anti-CrkL (phospho Y207) antibody [CrkLY207-G4] (ab278698) at 0.001 µg/ml
Lane 1 : K562 cell extract untreated
Lane 2 : K562 cell extract treated with imatinib
Predicted band size: 34 kDa
-
Flow cytometric analysis of K562 cells secondary antibody only negative control (blue) or imatinib (red) or treated with pervanadate (green) using ab278698 at 0.05 µg/mL. .
-